Clinical Toxicology Research Group, University of Newcastle, Newcastle, NSW, Australia.
Department of Parasitology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Anuradhapura, Sri Lanka.
Clin Toxicol (Phila). 2024 May;62(5):280-287. doi: 10.1080/15563650.2024.2349690. Epub 2024 May 28.
Myotoxicity is an important toxidrome that can occur with envenoming from multiple Australian snake types. Early antivenom administration is an important strategy to reduce the incidence and severity of myotoxicity. The current gold standard biomarker, serum creatine kinase activity, does not rise early enough to facilitate early antivenom administration. Several other skeletal muscle biomarkers have shown promise in other animal models and scenarios. The aim of this study was to examine the predictive values of six skeletal muscle biomarkers in a rat model of Australian snake myotoxicity.
Sprague-Dawley rats were anaesthetised and administered either (red-bellied black snake) or (tiger snake) venom, or normal saline via intramuscular injection. Blood samples were collected. Assays were performed for serum creatine kinase skeletal muscle troponin-I concentration, skeletal muscle troponin-C concentration, myoglobin activity, skeletal muscle myosin light chain-1 concentration, and creatine kinase-MM activity. Serum markers were plotted against time, with comparison of area under the concentration (or activity)-time curve. The predictive values of six skeletal muscle biomarkers were examined using receiver operating characteristic curves.
There was no difference in area under the serum creatine kinase activity-time curve between venom and control groups. Serum creatine kinase-MM activity rose early in the venom treated rats, which had a significantly greater area under the serum activity-time curve. No difference in area under the serum concentration-time curve was demonstrated for the other biomarkers. Creatine kinase-MM activity had a superior predictive values than creatine kinase activity at 0-4 hours and 0-10 hours after venom administration, as indicated by area under the receiver operating characteristic curves (95 per cent confidence intervals) of 0.91 (0.78-1.00) and 0.88 (0.73-1.00) versus 0.79 (0.63-0.95) and 0.66 (0.51-0.80).
The limitations of serum creatine kinase activity in early detection of myotoxicity were demonstrated in this rat model.
Serum creatine kinase-MM activity was superior for early detection of Australian myotoxic snake envenoming.
肌毒性是一种重要的中毒症状,可能发生在多种澳大利亚蛇类的咬伤中毒中。早期使用抗蛇毒血清是减少肌毒性发生率和严重程度的重要策略。目前的金标准生物标志物血清肌酸激酶活性升高不够早,无法促进早期使用抗蛇毒血清。其他一些骨骼肌生物标志物在其他动物模型和情况下显示出了前景。本研究旨在检查六种骨骼肌生物标志物在澳大利亚蛇类肌毒性大鼠模型中的预测价值。
用麻醉剂麻醉 Sprague-Dawley 大鼠,通过肌肉内注射给予 (红腹黑蛇)或 (虎蛇)毒液或生理盐水。采集血液样本。进行血清肌酸激酶、骨骼肌肌钙蛋白-I 浓度、骨骼肌肌钙蛋白-C 浓度、肌红蛋白活性、骨骼肌肌球蛋白轻链-1 浓度和肌酸激酶-MM 活性的测定。将血清标志物与时间进行绘制,并比较浓度(或活性)-时间曲线下的面积。使用受试者工作特征曲线检查六种骨骼肌生物标志物的预测价值。
毒液组和对照组血清肌酸激酶活性-时间曲线下面积无差异。血清肌酸激酶-MM 活性在接受毒液治疗的大鼠中早期升高,其血清活性-时间曲线下面积明显更大。其他生物标志物的血清浓度-时间曲线下面积无差异。肌酸激酶-MM 活性在毒液给药后 0-4 小时和 0-10 小时的预测价值优于肌酸激酶活性,如受试者工作特征曲线下面积(95%置信区间)分别为 0.91(0.78-1.00)和 0.88(0.73-1.00)与 0.79(0.63-0.95)和 0.66(0.51-0.80)。
本大鼠模型证明了血清肌酸激酶活性在早期检测肌毒性方面的局限性。
血清肌酸激酶-MM 活性在早期检测澳大利亚肌毒性蛇咬伤方面更具优势。